Dr. Flavia Oliveira Mendes, MD

Dr. Mendes practices at Advanced Cardiovascular of Miami in Miami, Florida.

Dr. Mendes' NPI, 1487628582, was assigned on February 15, 2006. Dr. Mendes graduated from Federal University of Ceara Faculty of Medicine in 1997. Dr. Mendes holds Florida license ME0096220.

Dr. Mendes' primary practice is Advanced Cardiovascular of Miami, at 9408 Sw 87th Ave, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 474-3211.

Dr. Mendes' primary practice is Advanced Cardiovascular of Miami in Miami, Florida. Dr. Mendes is also affiliated with Baptist Health Baptist Hospital. The medical group on file is Gastro Health. Dmand AI also links Dr. Mendes to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mendes practices, 5 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Mendes' primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Mendes is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Mendes' licenses on file in 2 states: Florida and Minnesota.

Dmand AI lists acid reflux, cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis, hemorrhoids, hepatitis c and irritable bowel syndrome (IBS) among the conditions Dr. Mendes treats.

CMS data shows 354 Medicare services from Dr. Mendes across 10 procedure codes in 2024, for 215 Medicare patients. Medicare paid $30,031 for them.

CMS counts 215 Medicare patients who saw Dr. Mendes in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mendes' median patient age at 61, with 66% women.

In 2024, Dr. Mendes wrote 905 Medicare Part D claims for 269 patients. 79% of them were for generic drugs. CMS names the drug for 741 of them, across 23 drugs with 11 or more claims each, at $403,575 in total drug cost. In 2023, CMS named 692 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Mendes for performance year 2024, reported as part of a group. Dr. Mendes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mendes as offering telehealth. CMS counts 29 procedures of colonoscopy by Dr. Mendes, more than 53% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. Mendes, published from 2005 to 2016. 2006 was the busiest year, with 3. The most frequent topics are Cholangitis, Sclerosing, Fatty Liver and Hypertension, Portal. Dr. Mendes has published most often in Am J Gastroenterol. Dr. Mendes' most frequent co-authors are Cynthia Levy, MD, Victor R. Araya, MD and Pablo A. Bejarano.

Dmand AI links Dr. Mendes to 1 clinical trial. Conditions studied include Non-alcoholic Fatty Liver Disease and Fatty Liver.

CMS Open Payments shows 148 general payments to Dr. Mendes from 26 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 62% of the total. Intercept Pharmaceuticals, Inc. paid the most, $4,740.

Dmand AI lists 1 award for Dr. Mendes, most recently CMS Stage 1 2012 in 2011.

Dr. Mendes graduated from Federal University of Ceara Faculty of Medicine in 1997.

Dr. Mendes is in network with 16 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.